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Introduction
Human herpesvirus-8 (HHV-8), also known as Kaposi’s 
sarcoma-associated herpesvirus (KSHV), is considered 
the casual agent of Kaposi’s sarcoma (KS), the most 
common cancer related to acquired immunodeficiency 
syndrome (AIDS) in many African countries including 
Zambia [Moore and Chang, 1995; Newton et al., 2003a]. 
The worldwide prevalence and risk factors of HHV-8 
infection vary geographically and across population 
groups. In North America and Northern/Western Eu-
rope, infection is rare, not exceeding 5% among healthy 
blood donors [Gao et al., 1996; Whitby et al., 1998]. In KS 
endemic areas, such as Greece, Southern Italy, and sub-
Saharan Africa, prevalence of the virus is much higher, 
particularly among population groups such as elderly 
men [Cattani et al., 2003]. In recent years, studies con-
ducted in Africa reported HHV-8 seropositivity between 
32% and 100% in adult populations [Bestetti et al., 1998; 
He et al., 1998; Olsen et al., 1998; Enbom et al., 1999; Sitas 
et al., 1999; Serraino et al., 2001; Baeten et al., 2002; DeSan-
tis et al., 2002; Lavreys et al., 2003; Mbulaiteye et al., 2003; 
Newton et al., 2003b]. However, reports from the central 
sub-Saharan region on HHV-8 prevalence and associated 
risk factors are limited and typically based on convenient 
sampling methods and small numbers of study partici-
pants. This is mainly due to lack of routine screening for 
this virus. In sub-Saharan countries such as Zambia, a 
large percentage of women and children diagnosed with 
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HHV-8 and/or KS are co-infected with HIV-1, suggest-
ing that HIV-1 infection could somehow be related to 
HHV-8 infection [Athale et al., 1995; He et al., 1998; El-
tom et al., 2002; Newton et al., 2003a]. Although a higher 
prevalence of HHV-8 has been documented in HIV-1 in-
fected individuals than in the healthy general population 
[Nuvor et al., 2001; Eltom et al., 2002; Hladik et al., 2003], 
the role of HHV-8 in facilitating HIV-1 infection requires 
further investigation [Moore and Chang, 1995; Newton 
et al., 2003a]. Various studies have suggested that both 
sexual [Martin et al., 1998; Sosa et al., 1998; Grulich et al., 
1999; Rezza et al., 2000; Baeten et al., 2002] and nonsexual 
[Blauvelt et al., 1997; Whitby et al., 1998; Andreoni et al., 
1999; Mantina et al., 2001] modes of transmission are cor-
related with HHV-8 seropositivity. Prior epidemiologi-
cal reports have indicated that certain high-risk sexual 
practices (e.g., anal intercourse) [Melbye et al., 1998; Re-
gamey et al., 1998; Eltom et al., 2002; Renwick et al., 2002], 
work as a commercial sex worker or prostitute [Sosa et 
al., 1998; Challine et al., 2001; Eltom et al., 2002; de San-
jose et al., 2002], coinfection with other pathogens such 
as HIV-1, HBV, and HCV [Sosa et al., 2001; Lavreys et al., 
2003; Newton et al., 2003a], intravenous drug use and ex-
posure to blood products [Cannon et al., 2001; Sosa et al., 
2001; Hladik et al., 2003], or oral secretions including sa-
liva [Blauvelt et al., 1997; Blackbourn et al., 1998; Pauk et 
al., 2000] are also associated with HHV-8 seropositivity.
To examine HHV-8 seroepidemiology and associated 
risk factors, we analyzed data collected prospectively on 
a large population of antenatal Zambian women. Identi-
fication of risk determinants for HHV-8 among African 
antenatal women may provide some insight on possible 
routes of virus transmission in this population.
Materials and Methods
Design and Study Population
In this study, we report the findings from analyses of 
cross-sectional data and enrollment visit data from a pro-
spective cohort study on pathogenesis and transmission 
of HHV-8 infection. The study objective was to determine 
seroprevalence estimates and associated risk factors for 
HHV-8. The local Research and Ethics Review Commit-
tee of the University Teaching Hospital (UTH), Lusaka, 
Zambia and the Zambian Ministry of Health approved 
the study protocols.
The study took place in Zambia, a central sub-Saharan 
African countrywith an estimated population of 9 mil-
lion. A total of 3,160 women were recruited to participate 
in the study at UTH, the largest tertiary care institution in 
the country and the main referral center for Lusaka, the 
capital of the country. As the referral center of Lusaka, 
approximately 20% of women admitted annually are 
referred to UTH for special care such as multiple preg-
nancy, Caesarean section, severe anemia, young age, hy-
pertension, tuberculosis, malaria, or other opportunistic 
infections including AIDS. Between September 1998 and 
October 2000, women admitted to the labor ward were 
approached for enrollment in the study. Those who were 
clinically diagnosed with KS, AIDS, TB, malaria, or can-
cer or had any other health conditions that might have 
affected their immune systems were not eligible to par-
ticipate in the study. In addition, women had to reside in 
the metropolitan area of Lusaka. Disease histories as well 
as physical examinations were carried out to rule out any 
clinical symptoms or visible signs for these conditions.
Data Collection
All study subjects signed informed consent and were 
evaluated by study clinicians. A set of pre-tested, stan-
dardized questionnaires was used to gather data. All 
personal identifiers were removed to ensure patient con-
fidentiality. Medical history information were retrospec-
tively retrieved, with patients’ permission, from hospital 
medical records.
A total of 154 variables were identified and assessed in 
this study. Data were collected on seven domains of inter-
est that included the following: (1) socio-demographics 
(age, tribal identity, education, marital status, religion, 
occupation, and household income); (2) current medical 
status (weight, diagnosis of tuberculosis, and diagnosis 
of specific ulcerative and non-ulcerative STDs); (3) medi-
cal history (histories of blood transfusion, hypertension, 
drug abuse, and use of antibiotics in past 12 months); 
(4) reproductive and obstetric history (number and out-
comes of pregnancies, use of family planning and birth 
control methods including condoms); (5) sexually trans-
mitted disease history (histories of STDs, genital ulcer-
ation, vaginal discharge, and cancer including cervical 
dysplasia); (6) sexual behavior history (age at first sexual 
encounter, steady partner in past 3 years, new partners 
in past 3 years, sex with partner with penile lesion, sex 
under influence of alcohol, anal intercourse, being raped, 
practice of dry sex, and use of herbs vaginally; and (7) 
laboratory test results (results of serological testing for 
HHV-8, HIV-1, and syphilis).
Laboratory Testing
Blood specimens were collected by venipuncture into 
acid citrate dextrose tubes and processed using centrifu-
gation at the on-site study laboratory within 6 hr of being 
drawn. The separated plasma was frozen at 208C and the 
blood cells at 808C. All specimens were then shipped to 
the Nebraska Center for Virology at the University of 
Nebraska-Lincoln (UNL) for serological testing.
Plasma was tested for HHV-8 antibodies by indirect IFA 
using HHV-8 infected BC-3 cells, an HHV-8 positive and 
an Epstein–Barr virus (EBV) negative B-cell lymphoma 
cell line as a target (kindly provided by Dr. Ethel Cesar-
man, Cornell University). The IFA test was performed 
using the procedure described by Lennette et al. [1996] 
with minor modifications. Briefly, 5 x 105 cells/ml were 
stimulated with tetra decanoyl phorbol acetate (TPA, 20 
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ng/ml, Sigma, St. Louis, MO) for 72 hr in culture medium 
(90% RPMI 1640, 10% fetal calf serum, 100 U/ml penicil-
lin G, and 100 μg/ml streptomycin). Two different lab 
technicians verified the IFA from each specimen at 1:40 
dilution. To exclude false positive results due to back-
ground staining, all positive plasma were re-tested with 
BJAB cells (an HHV-8 negative B lymphoma cell line).
The HIV-1 serological status was established using two 
rapid assays, Capillus (Trinity Biotech, Bray Co., Wick-
low, Ireland) and Determine (Abbott Laboratories, Ab-
bott Park, IL), following the manufacturers’ suggested 
procedures. Plasma that tested positive by a Capillus as-
say was confirmed by a Determine assay and vice versa.
Testing for syphilis involved the rapid plasma reagin 
assay (RPR, Arlington Scientific, Inc., Springville, UT) 
and a (Treponema pallidum) hemaglutination assay using 
the Serodia®-TPHA kit (Fujirebio, Inc., Tokyo, Japan). To 
avoid reporting biological false positive reactions, active 
syphilis was not considered to be present unless both as-
says were reactive.
Statistical Analyses
Given the cross-sectional design of the study, point and 
period prevalence estimates for HHV-8 were calculated. 
Associations between risk factors and HHV-8 positive 
serology were assessed using two-tailed X2-tests with 
continuity correction and a significance level of 0.05. 
Odds ratios (OR) and 95% confidence intervals (CI) were 
determined via univariate and multivariate analyses. 
Frequencies were calculated for categorical variables 
and means/standard deviations were calculated for con-
tinuous variables.
Univariate analyses of categorical variables were eval-
uated by X2-test with P-values <0.05 being considered 
significant. An independent t-test was used when com-
paring continuous variables. Associations represented 
by OR and P-value were appraised for statistical signif-
icance either by 95% CI and/or by the statistical tests. 
Multivariate logistic regression, with stepwise backward 
procedure, was performed to control potentially con-
founding factors (SAS version 8). CI were calculated 
based on coefficients and standard errors from the lo-
gistic model [Hosmer and Lemeshov, 1989]. In addition, 
approximate CI were provided for proportions [Rosner, 
1990]. All covariates that had a significant univariate as-
sociation with the outcome of interest were included in 
the regression model. A variable remained in the model 
if either the likelihood ratio test was significant (P < 0.05) 
or the estimates of the β coefficients for other variables 
in the model changed by at least 10%. Multivariate OR 
and 95% CI were used to quantify the relationships in 
estimates while P-values were calculated to imply the 
statistical significance. The regression model was evalu-
ated further by Hosmer–Lemeshov goodness-of-fit X2-
test [Hosmer and Lemeshov, 1989].
Results
Characteristics of the Study Population
Of approximately 10,000 pregnant women who at-
tended UTH clinics during the study period, 6,525 women 
were admitted to the labor ward with 92% of those being 
screened for participation in the study. Of 3,470 women 
who met specific study inclusion criteria, 310 (8.9%) re-
fused to participate in the study. The main reasons for 
refusal, from most frequent to least, were: need to con-
sult husband, not interested, live too far away, involved 
in other studies, do not want to know the test results, fear 
blood drawing, and cannot afford for transportation to 
come back for study follow-up visits.
The socio-demographic characteristics of the study pop-
ulation (n = 3,160) are presented in Table 1. The women’s 
median age was 25 years of age (standard deviation of  5.3) 
Table 1. Socio-Demographic Characteristics by Human 
Herpesvirus-8 (HHV-8) Status
aNumbers do not count up to the cell denominator (frequency by vari-
able category) due to missing values.
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with a range from 14 to 43 years of age. The vast ma-
jority (91%) of the women reported partnered relation-
ships (e.g., formal or common-law marriage) and the 
remainder was single. Approximately 80% were house-
wives, 7% were self-employed, 11% held odd jobs, and 
2% were students. Given a mean number of five persons 
per household (range 1–25), half of the women reported 
a family income below the local poverty level of US $50 
per month. Approximately, one of two women had com-
pleted primary education (/7 years), while the remain-
der had either gone through grade 12 (40%) or had some 
tertiary education (5%). The women’s median age at the 
time of their first sexual encounter was 16 years.
Prevalence of HHV-8 and Socio-Demographic 
Characteristics
For analytical purposes, the study recruitment period 
was divided into four testing intervals. The HHV-8 pe-
riod prevalence was found to be stable, ranging from 
38% to 42% in each testing interval. During the period 
from September to December 1998, 334 (41%) tested 
positive, from January to June 1999, 302 (40%) tested 
positive, from July 1999 to January 2000, 308 (42%) tested 
positive, and from February to October 2000, 313 (38%) 
tested positive. The overall prevalence was 40.2% for 
HHV-8 (1,257/3,131; 95% CI 38.5–41.9) and 29.9% for 
HIV-1 (913/3,058; 95% CI 28.2–31.5). Co-infection with 
both pathogens was not uncommon, 13.6% (426/ 3,131; 
95% CI 12.8–15.2). Moreover, HHV-8 positive women 
were more likely to be infected with HIV-1 than those 
who were HHV-8 negative (34% vs. 26%; P < 0.0001; OR 
¼ 1.5; 95% CI 1.2–1.7) (Table 2).
The proportion of HHV-8 positive women was stable 
(39%–41%) across all age groups (Table I). The predomi-
nant tribal group, Ngoni (44%), had the highest preva-
lence of HHV-8 (43%) but the lowest prevalence of HIV-1 
(28%) when compared to other tribal groups. Women 
with primary education were more likely to be posi-
tive for HHV-8 (42%), but less likely to be infected with 
HIV-1 (26%) when compared with those who completed 
secondary and/or tertiary education (38% for HHV-8 
and 34% for HIV-1).
Univariate Determinants of HHV-8 Infections
Several variables were found to be associated with 
positive HHV-8 serology. Two of the well-defined risk 
behaviors for contracting sexually transmitted diseases, 
intravenous drug use and anal sexual intercourse, were 
practically non-existent (0.9% and 0.4%, respectively) in 
the study population.
HHV-8 positive status was found to associate with 
women’s primary education, diagnosis of syphilis and 
genital warts, histories of STDs and genital ulceration, 
and positive serological test results for HIV-1 and T. pal-
lidum. All variables, despite relatively low OR, showed 
statistical significance (Table 3); the highest risk estimate 
was associated with the diagnosis of genital warts (OR = 
1.62; 95% CI 1.2–2.2; P < 0.001).
Independent Risk Predictors of HHV-8 Infection
All variables from the univariate analyses were entered 
into multiple logistic regression models to identify inde-
pendent predictors of HHV-8 positive serology. The de-
tailed results are presented in Table 3. Additional analy-
ses were performed to investigate whether regressed 
variables that had been eliminated by the statistical pro-
cedure should be reintroduced into the final models. The 
results indicated that none of the re-tested parameters 
either separately or together had any significant effect 
on the model’s predictability and were not included in 
Table 3.
Of the seven risk factors found to associate with HHV-8 
in the univariate analyses, only three variables:
primary education (P = 0.005; OR ¼ 1.2; 95% CI 1.1– 1.4), 
diagnosis of genital warts (P = 0.01; OR ¼ 1.5; 95% CI 
1.1–2.0), and HIV-1 positive serology (P < 0.0001; OR = 
1.4; 95% CI 1.2–1.7) demonstrated statistically significant 
association with HHV-8 positive status by multiple lo-
gistic regression analysis (Table 3). The risk estimates for 
diagnosis of genital warts and positive HIV-1 serology 
were slightly higher, as compared with similar univari-
ate estimates. Of the women analyzed, 84% had at least 
one independent risk predictor for HHV-8 infection. 
Among the remaining 16%, with no identifiable risk fac-
tors for HHV-8, 16% were HHV-8 infected, while 11% 
were HHV-8 negative. Suitability of the regression model 
in predicting HHV-8 infection was then evaluated by X2 
goodness-of-fit test. The results showed an excellent fit 
of the data in the model (X2 = 0.36; degrees of freedom = 
3; P = 0.95). The model correctly predicted 95% of HHV-8 
positive women as the truly HHV-8 positive women, as 
per Hosmer–Lemeshov X2 goodness-of-fit test.
Table 2. HHV-8 and HIV-1 Serological Status
aMissing category includes subjects who were tested neither for HHV-8 nor HIV-1 or had insufficient/contaminated blood specimens.
bPercentages in parentheses represent percentage positive for HHV-8 and percentage in italics represents percentage positive for HIV.
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Discussion
This is the first study to report the comprehensive 
epidemiological characteristics of HHV-8 infection in 
a large population of antenatal women in Zambia. The 
high prevalence of infection observed in the study popu-
lation is consistent with the findings of similar studies 
of pregnant [Bestetti et al., 1998; de-The et al., 1999; Man-
tina et al., 2001] and non-pregnant women [Bestetti et al., 
1998; He et al., 1998; Enbom et al., 1999; Rezza et al., 2000; 
Cook et al., 2002; DeSantis et al., 2002; Lavreys et al., 2003; 
Mbulaiteye et al., 2003] from other regions of Africa.
In our study, the high and relatively stable period 
prevalence of HHV-8 observed throughout the 2-year 
testing period indicates that this infection is well estab-
lished in the study population. Furthermore, three risk 
factors including primary education, diagnosis of geni-
tal warts, and HIV-1 positive serology were indepen-
dently associated with HHV-8 infection in the logistic 
regression analysis. Given that women’s lower level of 
education (≤7 years) was a predictor of HHV-8 infection, 
which was further correlated with lower socioeconomic 
status, one can speculate that poor living/environmental 
conditions (e.g., familial aggregation, household sanitary 
conditions) may play a role in non-sexual transmission 
of the virus, perhaps via saliva or nasal secretions [Blau-
velt et al., 1997; Blackbourn et al., 1998; DeSantis et al., 
2002]. Surprisingly, in our study, several sexual behavior 
variables, such as a past history of STD, including genital 
ulceration and diagnosis of syphilis, did not show a sta-
tistically significant relationship with HHV-8 in the mul-
tivariate model despite strong univariate correlations. 
Nevertheless, the diagnosis of genital warts emerged as 
the strongest predictor of HHV-8 seropositivity and may 
suggest sexual transmission of the virus. This assump-
tion is supported by the results of recent studies, which 
documented an association between HIV-1, human pap-
illomavirus (HPV), and genital warts [O’Farrell, 1999; 
Bleeker et al., 2002; Silverberg et al., 2002]. Our finding 
of an association between HIV-1 and HHV-8 infection 
in our population confirms previous reports [Martin et 
al., 1998; Hladik et al., 2003; Newton et al., 2003a] and 
the suggested epidemiological association of KS with 
HIV-1 [Sitas et al., 1997; Amir et al., 2001; Newton et al., 
2003a]. However, there are contrary reports suggesting 
that there is no relationship between HIV-1 and HHV-8 
infection [Baeten et al., 2002; DeSantis et al., 2002; Mar-
celin et al., 2002]. It is likely that these discrepancies are 
due to differences in cohort populations and the assays 
used for HHV-8 diagnoses. Our IFA-based serological 
assays were designed to detect both HHV-8 lytic and la-
tent antigens. The detection of either one was considered 
sufficient criterion for a positive designation. Recently, 
we have developed a baculovirus-based recombinant 
antigen IFA and have found over 95% concordance be-
tween our original IFA and the insect-based IFA (unpub-
lished data). Considering our large population size and 
the concordance between our serological assays, we be-
lieve that the observed correlation between HIV-1 and 
HHV-8 infection in our studied population is valid. Even 
though there is no reported mechanism describing how 
HIV-1 facilitates HHV-8 transmission, or vice versa, it is 
possible that HIV-1 induced immunosuppression could 
enhance the susceptibility to HHV-8 infection or could 
increase the viral load in dually infected donors. HIV-1 
infection could also be an indicator of a particular sex-
ual behavior that is associated with the transmission of 
both HIV-1 and HHV-8. Despite high prevalence of both 
HHV-8 and HIV-1 infections, a relatively small propor-
tion of women were found to be infected with both vi-
ruses. If the acquisition of these agents were independent 
events, it is possible that many of the dually HHV-8/
HIV-1 infected women acquired the HHV-8 virus, prior 
to becoming sexually active and then became coinfected 
with HIV-1 through the heterosexual contact, while the 
remainder (especially those infected with genital warts) 
could have contracted both HHV-8 and HIV-1 hetero-
sexually. The fact that pregnant women were co-infected 
with both viruses represents a public health concern, as 
the simultaneous presence of multiple pathogens may 
facilitate progression of these diseases (e.g., AIDS and 
KS) or transmission of other infectious agents (e.g., other 
herpesviruses and other STDs).
Value and Limitations
The cross-sectional design of this study provided a 
rapid method of risk estimation as compared with co-
hort studies. Its strength lies in the large number of study 
participants, the representative nature of the selected 
sample, the 2-year screening period, and the complexity 
of the data collected through structured interviews and 
medical record reviews. These attributes allowed us to 
investigate and characterize over 100 of the risk factors 
for HHV-8 infection that have not been well investigated 
by research reports from central sub-Saharan African 
countries, including Zambia.
We are aware, however, that the women’s serologi-
cal status and associated risk behaviors were evaluated 
not at the time of seroconversion, but at an undetermin-
able time point after initial infection. This might have 
misrepresented the associations. Since many variables 
were examined for our outcome of interest, it is pos-
sible that some proportion of our findings were due to 
chance as well. Thus, the temporal nature of associations 
could not be determined. In addition, whether the study 
results presented here can provide a definite answer 
as to whether the identified risk estimates for HHV-8 
among antenatal women are the same as those in a gen-
eral population of non-pregnant women of childbear-
ing age in Lusaka, Zambia needs further investigation.
Conclusions
This is the first comprehensive, epidemiological assess-
ment of HHV-8 infection in antenatal women in a central 
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sub-Saharan African country. The independent associa-
tion of HHV-8 with HIV-1 infection, genital warts, and 
women’s lower level of education (≤7 years) suggests that 
sexual as well as non-sexual transmission of HHV-8 oc-
curs in Zambia and other HHV-8 endemic regions. This 
finding warrants further studies on virus transmission. 
It also suggests that HIV-1 infection in pregnant women 
and likely women in general is largely undiagnosed and 
certainly underreported. Since HHV-8 facilitates develop-
ment of AIDS-associated KS, the HHV-8 prevalence and 
risk behaviors identified in this study could be utilized to 
identify specific population groups of pregnant women 
who are at increased risk for the development of KS.
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